Loading…
Sanofi Consumer Healthcare India (SANOFICONR)₹3,449−1.36%Pharmaceuticals
In the Jun 2026 quarter (standalone), Sanofi Consumer Healthcare India reported sales of ₹236 Cr, up 6.9% from Jun 2025, and net profit of ₹68.89 Cr, up 13.2% year on year. For the year to Dec 2025, sales were ₹876 Cr and net profit ₹240 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 209 | 225 | 222 | 172 | 160 | 171 | 173 | 220 | 233 | 250 | 229 | 236 |
| Expenses | 116 | 135 | 140 | 109 | 96.99 | 109 | 109 | 151 | 149 | 161 | 140 | 146 |
| Operating Profit | 94.81 | 89.95 | 81.85 | 63.96 | 62.95 | 61.87 | 63.95 | 69.90 | 84.89 | 89.91 | 88.92 | 88.87 |
| OPM % | 45.0% | 40.0% | 37.1% | 37.0% | 39.0% | 36.0% | 37.1% | 32.0% | 36.1% | 36.0% | 39.0% | 38.0% |
| Other Income | 1.01 | 1.01 | 3.01 | −24.06 | 3.01 | 2.01 | 5.01 | 12.02 | 3.01 | 5.01 | 6.01 | 6.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 1.01 | 2.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Profit before tax | 95.17 | 90.17 | 84.10 | 39.09 | 61.07 | 63.14 | 67.10 | 79.07 | 84.14 | 90.22 | 91.22 | 92.08 |
| Tax % | 25.0% | 24.0% | 25.0% | 25.0% | 26.0% | 29.0% | 25.0% | 23.0% | 25.0% | 27.0% | 25.1% | 25.1% |
| Exceptional items | 0.00 | −1.01 | 0.00 | −16.02 | −1.01 | −2.01 | 0.00 | 5.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 70.86 | 67.92 | 62.90 | 28.98 | 44.93 | 43.94 | 49.94 | 60.88 | 62.90 | 65.87 | 67.89 | 68.89 |
| EPS (Rs) | — | — | — | 12.57 | 19.48 | 19.21 | 21.65 | 26.31 | 27.23 | 28.78 | 29.36 | 29.80 |
| Dec 2023 8m | Dec 2024 | Dec 2025 | TTM | |
|---|---|---|---|---|
| Sales | 554 | 722 | 876 | 948 |
| Expenses | 337 | 454 | 569 | 596 |
| Operating Profit | 219 | 270 | 309 | 353 |
| OPM % | 39.0% | 37.0% | 35.0% | 37.2% |
| Other Income | 2.01 | −15.02 | 25.05 | 20.04 |
| Interest | 0.00 | 4.01 | 2.01 | 1.01 |
| Depreciation | 2.01 | 4.01 | 12.01 | 12.04 |
| Profit before tax | 219 | 248 | 321 | 358 |
| Tax % | 25.0% | 27.0% | 25.0% | — |
| Exceptional items | −1.01 | −20.05 | 5.01 | 0.00 |
| Net Profit | 165 | 181 | 240 | 266 |
| EPS (Rs) | — | 78.46 | 103.94 | 115.17 |
| Dividend payout % | 6.0% | 70.0% | 72.0% | — |
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
| Equity Capital | 2.01 | 23.04 | 23.05 |
| Reserves | 206 | 251 | 362 |
| Borrowings | 0.00 | 20.05 | 25.07 |
| Other Liabilities | 138 | 138 | 139 |
| Total Liabilities | 346 | 432 | 549 |
| Fixed Assets | 4.99 | 28.98 | 36.02 |
| CWIP | 2.99 | 0.99 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| Other Assets | 339 | 403 | 512 |
| Inventories | 96.94 | 40.99 | 61.94 |
| Trade receivables | 32.11 | 14.05 | 30.10 |
| Cash & equivalents | 2.01 | 327 | 376 |
| Total Assets | 346 | 432 | 549 |
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
| Cash from operating activity | 0.00 | 440 | 175 |
| Cash from investing activity | 0.00 | 2.01 | 8.03 |
| Cash from financing activity | 2.01 | −116 | −134 |
| Net cash flow | 1.99 | 325 | 47.89 |
| Capex | 4.01 | 9.91 | 7.62 |
| Free cash flow | −3.99 | 428 | 167 |
| CFO / OP % | 2.0% | 208.0% | 85.0% |
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
| Debtor days | 21 | 7 | 12 |
| Inventory days | 232 | 80 | 98 |
| Days payable | 143 | 137 | 125 |
| Cash conversion cycle | 109 | −51 | −16 |
| Working capital days | 134 | −33 | −4 |
| ROCE % | — | 111.0% | 90.0% |
For the Jun 2026 quarter, Sanofi Consumer Healthcare India reported sales of ₹236 Cr, up 6.9% year on year and net profit of ₹68.89 Cr, up 13.2% year on year. The operating margin was 38.0%.
Sanofi Consumer Healthcare India's sales for the year to Dec 2025 were ₹876 Cr; over the last twelve months they were ₹948 Cr.
Net profit for the year to Dec 2025 was ₹240 Cr, and ₹266 Cr over the last twelve months. Earnings per share over the same trailing period were ₹115.17.
Sanofi Consumer Healthcare India reported borrowings of ₹25.07 Cr at Dec 2025, against cash and equivalents of ₹376 Cr.
Cash from operations was ₹175 Cr in the year to Dec 2025; after capital spending, free cash flow was ₹167 Cr.